Comprehensive Financial Consultants Institutional’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $244K | Hold |
1,932
| – | – | 0.08% | 170 |
|
2025
Q1 | $247K | Sell |
1,932
-971
| -33% | -$124K | 0.09% | 160 |
|
2024
Q4 | $384K | Sell |
2,903
-1,030
| -26% | -$136K | 0.14% | 132 |
|
2024
Q3 | $573K | Sell |
3,933
-255
| -6% | -$37.1K | 0.21% | 114 |
|
2024
Q2 | $575K | Sell |
4,188
-5
| -0.1% | -$686 | 0.23% | 111 |
|
2024
Q1 | $575K | Hold |
4,193
| – | – | 0.24% | 113 |
|
2023
Q4 | $570K | Hold |
4,193
| – | – | 0.26% | 108 |
|
2023
Q3 | $513K | Hold |
4,193
| – | – | 0.27% | 109 |
|
2023
Q2 | $542K | Buy |
4,193
+100
| +2% | +$12.9K | 0.29% | 106 |
|
2023
Q1 | $529K | Buy |
4,093
+30
| +0.7% | +$3.88K | 0.3% | 105 |
|
2022
Q4 | $549K | Buy |
4,063
+9
| +0.2% | +$1.22K | 0.33% | 104 |
|
2022
Q3 | $496K | Sell |
4,054
-272
| -6% | -$33.3K | 0.33% | 104 |
|
2022
Q2 | $534K | Sell |
4,326
-65
| -1% | -$8.02K | 0.38% | 101 |
|
2022
Q1 | $497K | Buy |
4,391
+400
| +10% | +$45.3K | 0.35% | 102 |
|
2021
Q4 | $504K | Buy |
+3,991
| New | +$504K | 0.32% | 96 |
|